Clinical Trials Sponsored by Betta Pharmaceuticals Co., Ltd.

Total 3752 results

Kissei Pharmaceutical Co., Ltd.

Completed

A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation

Chronic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation

Chronic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Peritoneal Dialysis | Hyperphosphatemia

Japan
IlDong Pharmaceutical Co Ltd

Completed

Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects

Healthy
Sinphar Pharmaceutical Co., Ltd

Completed

Phase IIb Study of STA-2 in Patients With Chronic Stable Angina

Chronic Stable Angina

Taiwan
Sinphar Pharmaceutical Co., Ltd

Unknown

Study of STA-1 as an Add-on Treatment to Donepezil

Alzheimer Disease

Taiwan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Stevens-Johnson Syndrome | Toxic Epidermal Necrolysis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Idiopathic Restless Legs Syndrome

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

Parkinson's Disease

Japan
IlDong Pharmaceutical Co Ltd

Completed

A Drug Interaction Study of Mosapride and Rebamipide

Healthy

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

Parkinson's Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

Parkinson's Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Parkinson's Disease

Japan
IlDong Pharmaceutical Co Ltd

Completed

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

Healthy Volunteers

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema

Cirrhosis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema

Cirrhosis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Schizophrenia

Japan
IlDong Pharmaceutical Co Ltd

Completed

A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer (PDF inhibitor)

Healthy

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)

Edema | Heart Failure, Congestive

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Confirmatory Study of OPC-12759 Ophthalmic Suspension

Dry Eye Syndromes

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Endometriosis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

Chronic Idiopathic Constipation

Japan
IlDong Pharmaceutical Co Ltd

Completed

Pharmacokinetic Study of Belviq in Adult Korean Volunteers

Healthy

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Completed

A Drug Interaction Study of Cilnidipine and Valsartan

Healthy

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Unknown

A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer

Advanced Breast Cancer

China
Ono Pharmaceutical Co. Ltd

Completed

A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women

Healthy Post Menopausal Women

United Kingdom
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

SCD

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

Dry Eye

Singapore, China
Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

Moderate to Severe Glabellar Line

Korea, Republic of
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Colorectal, Cancer

Japan
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Overactive Bladder
Daewoong Pharmaceutical Co. LTD.

Completed

Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers

Healthy
Daewoong Pharmaceutical Co. LTD.

Unknown

Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

Rheumatoid Arthritis

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers (MGF)

Anorexia | Cachexia

Korea, Republic of
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Gastric Cancer | Gastric Adenoma | Colon Nos Polypectomy Tubular Adenoma

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Gastric Cancer

Japan
Daewoong Pharmaceutical Co. LTD.

Unknown

Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome

Irritable Bowel Syndrome

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-8539 in Patients With Overactive Bladder

Overactive Bladder

Poland, Ukraine, Romania, Russian Federation, Czech Republic, Hungary, Netherlands, Sweden, Germany
Ono Pharmaceutical Co. Ltd

Completed

ONO-7436 Phase II Study in Japan

Malignant Tumor

Japan
Ono Pharmaceutical Co. Ltd

Completed

ONO-7746 Study in Healthy Adult Subject

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Coronary Artery Disease

Japan
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

Community-acquired Pneumonia

Japan
Ono Pharmaceutical Co. Ltd

Completed

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Belgium, France, Austria, Germany, Italy, Netherlands, Switzerland, United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-1078 in Patients With Chronic Sinusitis

Chronic Sinusitis

Japan

3

Subscribe